Company Profile
PerkinElmer Stock Price, News & Analysis
- Ticker:
- RVTY
- Exchange:
- NYSE
- Sector:
- MedTech
- Location:
- United States
Stock performance
114.24 USD (-0.68%)
Close
Last updated: August 6, 2026
11.2B USD
Market cap
Why the stock is moving
As of Aug 6, 2026, RVTY closed down 0.68% at $114.24. No new same-company headline was identified in the current news window.
Company overview
Business overview
Revvity is a life sciences tools and diagnostics company with exposure to discovery, reproductive health, applied markets, and clinical testing. The company evolved from PerkinElmer into a more focused platform around testing and life sciences infrastructure.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NYSE, Revvity has a global footprint in life sciences tools and diagnostics. It sits in research and diagnostic infrastructure, not therapeutics.
Business Model Characteristics
The company earns revenue from instruments, consumables, software, and diagnostic workflows. Investors focus on lab demand, prenatal and reproductive testing, and the health of research spending across its core markets.
Position Within the Biotechnology Landscape
Revvity sits in the biotech tools layer and benefits from the broader life sciences spending cycle. It is less binary than a drug stock, but it remains important because research and diagnostics budgets drive demand.
Future catalysts
Revvity’s catalysts are diagnostics demand, pharma-tools recovery, and any signs that the research-market backdrop is improving. This matters because it helps show whether the company can turn its current footprint into a cleaner earnings profile. Better execution here can matter even before a new product or trial headline lands.
Recent news
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of PerkinElmer (RVTY)?
PerkinElmer (RVTY) most recently closed at 114.24 USD, a -0.68% move versus the previous session.
What is the market cap of PerkinElmer (RVTY)?
PerkinElmer currently has a market capitalization of 11.2B USD on BioPharmSignal.
What does PerkinElmer do?
Revvity is a life sciences tools and diagnostics company with exposure to discovery, reproductive health, applied markets, and clinical testing. The company evolved from PerkinElmer into a more focused platform around testing and life sciences infrastructure.
On which exchange is RVTY stock listed?
PerkinElmer (RVTY) is associated with NYSE, United States, MedTech.
What is Revvity?
Revvity’s catalysts are diagnostics demand, pharma-tools recovery, and any signs that the research-market backdrop is improving.
Which conditions is PerkinElmer targeting with Revvity?
Revvity’s catalysts are diagnostics demand, pharma-tools recovery, and any signs that the research-market backdrop is improving.
How does PerkinElmer describe recent progress with Revvity?
Revvity’s catalysts are diagnostics demand, pharma-tools recovery, and any signs that the research-market backdrop is improving.
What is PerkinElmer?
The company evolved from PerkinElmer into a more focused platform around testing and life sciences infrastructure.